Skip to main content
. 2018 Nov 9;59(4):472–487. doi: 10.1002/jcph.1338

Figure 1.

Figure 1

Mean plasma concentration‐time (with standard deviation) curves of netupitant, its active metabolites M1, M2, and M3, and palonosetron after single administration of oral NEPA. NEPA, fixed combination of 300 mg netupitant and 0.50 mg palonosetron in a single capsule. Source: Study 8.